Skip to content

Carmel, Milazzo & Feil LLP client CTT Pharmaceutical (OTC: CTTH) receives strategic investment from Aurora Cannabis (TSE: ACB), one of the largest cannabis companies in the world

Aurora Cannabis Inc. (“Aurora” or the “Company”) (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) and CTT Pharmaceutical Holdings Inc. (“CTT”) (US-OTC: CTTH) today announced that Aurora is acquiring an initial 9.14% ownership interest in CTT via way of a non-brokered private placement in the form of a US$1 million 5% convertible debenture. The agreement…

Read More
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.